Home / Inspections / 1089083

FDA Inspection 1089083 — Catalent Pharma Solutions, LLC

Catalent Pharma Solutions, LLC — FEI 3007617094

The FDA completed an inspection of Catalent Pharma Solutions, LLC on April 16, 2019 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 16, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Philadelphia, PA (United States)

Facility

Other inspections at this facility

  • 1297392 (NAI Wed Dec 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1275086 (NAI Thu Jun 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 882445 (NAI Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources